Patents for A61P 35 - Antineoplastic agents (221,099)
05/2013
05/08/2013CN103083616A Traditional Chinese medicine for treating ovarian cyst
05/08/2013CN103083612A Traditional Chinese medicinal composition for treating cancers, and its preparation method
05/08/2013CN103083550A Oral liquid for preventing and treating gastric cancer and preparation method thereof
05/08/2013CN103083513A Method for preparing high-purity dioscorea nipponica makino total saponin
05/08/2013CN103083501A Soft capsule preparation for preventing and treating diseases of old people
05/08/2013CN103083477A Anti-tumor dripping pills
05/08/2013CN103083471A Cortex lycii radicis Chinese medical herb and brewing method thereof
05/08/2013CN103083463A Cancer pain plaster
05/08/2013CN103083388A Preparation method of fructus gleditsiae total saponins
05/08/2013CN103083364A Pharmaceutical composition for treating cancer
05/08/2013CN103083331A Application of solanum laciniatum ketene in preparing antitumor medicines
05/08/2013CN103083330A Application of solasodine in preparing antitumor medicines
05/08/2013CN103083329A Application of picriafel-terrae 1 in anti-tumor drug preparation
05/08/2013CN103083326A Ulipristal acetate medicine composition
05/08/2013CN103083324A Medicine and novel method used for intervening circulating tumor cell adhesion and infiltration into peripheral tissues
05/08/2013CN103083316A SNS-595 And Methods Of Using The Same
05/08/2013CN103083286A Toad venom lipophilic extract dry powder inhaler, as well as preparation method and application thereof
05/08/2013CN103083279A Polysaccharide sulfate soft capsule
05/08/2013CN103083273A Imatinib mesylate tablet cores, coated tablets, and preparation method thereof
05/08/2013CN103083268A Polysaccharide sulfate dispersible tablet
05/08/2013CN103083267A Polysaccharide sulfate chewable tablet
05/08/2013CN103083261A Polysaccharide sulfate freeze-dried powder injection
05/08/2013CN103083260A Gemcitabine hydrochloride for injection as well as preparation method thereof
05/08/2013CN103083251A Application of tanshinone IIA-polyactic acid/hydroxyacetic acid microsphere to preparation of antitumor drugs
05/08/2013CN103083250A Tanshinone IIA-polyactic acid/hydroxyacetic acid microsphere and preparation method thereof
05/08/2013CN103083249A Method for preparing berberine chitosan drug-carrying microsphere by salting-out process
05/08/2013CN103083248A Polysaccharide sulfate dry suspension
05/08/2013CN103083240A Preparation of solid dispersions and oral preparations of paclitaxel and homologous compounds thereof
05/08/2013CN103083239A Bufalin lipidosome, preparation method and application thereof
05/08/2013CN103083237A Lipid emulsion of magnolol and preparation method thereof
05/08/2013CN103083236A Fulvestrant containing oil needle preparation
05/08/2013CN103083233A Pharmaceutical composition of paclitaxel compound
05/08/2013CN103083231A Fulvestrant containing oil needle preparation
05/08/2013CN103083224A Method for preparing dexamethasone slow-release medicine carrier
05/08/2013CN102600180B Chinese medicinal active ingredient compound preparation for treating breast cancer and lung cancer and preparation method thereof
05/08/2013CN102579373B Amoitone B nano crystallization preparation and preparation method thereof
05/08/2013CN102552907B Application of non-surrounding displaced phthalocyanine zinc in preparing sonosensitizer
05/08/2013CN102475890B Acceptor protein, and coding gene and application thereof
05/08/2013CN102453079B Peptide specifically binding basic fibroblast growth factor receptor
05/08/2013CN102441012B Golden mushroom saponifiable extract product with antitumor effect, preparation method and application thereof
05/08/2013CN102319319B Solanum lyratum extract, and anticancer medicine comprising solanum lyratum extract
05/08/2013CN102319222B Decitabine freeze-dried preparation and preparation method thereof
05/08/2013CN102309457B Preparation method for nucleic acid nano-particle wrapping pharmacological active substances
05/08/2013CN102304178B Preparation method and application of African clawed toad antitumor polypeptide
05/08/2013CN102286071B Cyclic tetrapeptide compound and preparation method and use thereof
05/08/2013CN102276722B Novel vascular endothelial growth factor humanized monoclonal antibody
05/08/2013CN102258676B Composition for preventing lung cancer, and preparation method and application thereof
05/08/2013CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
05/08/2013CN102241665B 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof
05/08/2013CN102198243B Oviduct dredging medicament for removing blood stasis and warming meridians
05/08/2013CN102120029B Preparation method of alginate microparticles capable of inducing tumor immune response
05/08/2013CN102112133B Pharmaceutical uses of lanosta-8, 24-dien-3-ols
05/08/2013CN102076345B Liquid composition comprising cisplatin-coordinating compound
05/08/2013CN102060842B 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition
05/08/2013CN102020638B 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof
05/08/2013CN102008494B 20(R)-ginsenoside Rg3 medicinal water-solubility intermediate, freeze-dried powder injection and preparation method thereof
05/08/2013CN101970404B Novel method for the production of sulphonylpyrroles as hdac inhibitors
05/08/2013CN101959516B Methods of treating by inhibiting with quinaxoline inhibitors of PI3K-alpha
05/08/2013CN101921271B Pyridine [2,3-d] pyrimidone compounds and application thereof to pharmacy
05/08/2013CN101821243B Pyrimidinyl-propionic acid derivatives and their use as ppar agonists
05/08/2013CN101821236B Five-membered heterocyclic compound
05/08/2013CN101801955B Pyrimidyl cyclopentanes as akt protein kinase inhibitors
05/08/2013CN101801907B Compounds isolated from antrodia cinnamomea and use thereof
05/08/2013CN101778851B 稠合的双环嘧啶 Fused bicyclic pyrimidine
05/08/2013CN101712964B Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof
05/08/2013CN101631778B Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
05/08/2013CN101621997B Pharmaceutical composition
05/08/2013CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha
05/08/2013CN101252834B Plasma-depleted, non-red blood cell-depleted umbilical cord blood compositions and methods of use
05/08/2013CN101163503B Extending time to disease progression or survival in cancer patients using her dimerization inhibitor
05/08/2013CN101115766B Codon-optimized HPV16LI for salmonella vaccine strains against human papillomavirus type 16
05/07/2013US8436163 Splice-region antisense composition and method
05/07/2013US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide
05/07/2013US8436047 Preventive or ameliorating agent for liver disease involving hepatopathy
05/07/2013US8436012 Imidazopyridin-2-one derivatives
05/07/2013US8436010 Treatment of solid tumors with rapamycin derivatives
05/07/2013US8435992 Multiple myeloma treatments
05/07/2013US8435987 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
05/07/2013US8435981 2-(heterocyclylbenzyl)pyridazinone derivatives
05/07/2013US8435971 Use of 2,5-dihydroxybenzenesulfonic acid in the manufacturing of medicines, applicable to the treatment of angiodependent diseases
05/07/2013US8435958 Method for producing pectin hydrolysis products
05/07/2013US8435951 Treating neoplasms with neurotoxin
05/07/2013US8435543 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
05/07/2013US8435534 Cancer immunotherapy
05/07/2013CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
05/07/2013CA2715662C Phenylpropanoid diglycerides for the treatment of cancer
05/07/2013CA2681712C Tamibarotene capsule preparation
05/07/2013CA2659664C Improved radiation therapy methods
05/07/2013CA2607299C Compounds and compositions as protein kinase inhibitors
05/07/2013CA2596618C Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinoma
05/07/2013CA2564197C Activatable particles, preparations and uses
05/07/2013CA2538864C Thalidomide analogs as tnf-alpha modulators
05/07/2013CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/07/2013CA2491131C Novel compounds as histone deacetylase inhibitors
05/07/2013CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/02/2013WO2013063498A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies
05/02/2013WO2013063492A1 Novel compositions and methods for treating cancer
05/02/2013WO2013063482A2 Flt3 mutations associated with drug resistance in aml patients having activating mutations in flt3
05/02/2013WO2013063458A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
05/02/2013WO2013063417A1 Methyltransferase inhibitors for treating cancer